2018
DOI: 10.4172/2155-9880.1000597
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological Cardioversion by Intravenous Amiodarone for Primary Treatment of a Neonatal Atrial Flutter

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 9 publications
0
1
0
Order By: Relevance
“…11,12 In one study, it was reported that amiodarone treatment successfully converted atrial flutter to normal sinus rhythm without the application of electrical cardioversion. 13 In this study, a newborn infant with narrow QRS complex tachycardia was shown to have atrial flutter with a typical sawtooth pattern underlying after intravenous administration of adenosine. In addition, flecainide acetate, amiodarone, sotalol hydrochloride or combinations of these drugs were Figure 3.…”
Section: Discussionmentioning
confidence: 78%
“…11,12 In one study, it was reported that amiodarone treatment successfully converted atrial flutter to normal sinus rhythm without the application of electrical cardioversion. 13 In this study, a newborn infant with narrow QRS complex tachycardia was shown to have atrial flutter with a typical sawtooth pattern underlying after intravenous administration of adenosine. In addition, flecainide acetate, amiodarone, sotalol hydrochloride or combinations of these drugs were Figure 3.…”
Section: Discussionmentioning
confidence: 78%
“…11 Successful use of amiodarone therapy to achieve pharmacological cardioversion in stable babies has also been reported. 12 Use of amiodarone is also associated with various adverse effects. Common adverse effects reported in newborns include bradycardia, choreatic movements, hypothyroidism, elevation of liver enzymes, hypotension, and dysrhythmias.…”
Section: Discussionmentioning
confidence: 99%